Fig. 3. Molecular characterization and high-throughput drug screening using cancer organoids.

a PDO biobanks for gastrointestinal cancer were characterized by whole-genome sequencing, RNA sequencing, and single-cell sequencing. b High-throughput drug screening assays on generated PDO biobanks using differently sized anticancer drug libraries have been reported, allowing dose response analyses of the PDOs.